2019 Annual Meeting | C97 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know
Program Materials Program Evaluations
01:00 PM - 01:05 PM EDT | Introduction |
Introduction
Alison M. Pack, MD, FAAN |
01:05 PM - 01:25 PM EDT | Speaker |
Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond
Karen K. Miller, MD |
01:25 PM - 01:45 PM EDT | Speaker |
Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects
Alison M. Pack, MD, FAAN |
01:45 PM - 02:05 PM EDT | Speaker |
Influence of Neuroendocrine System on Multiple Sclerosis
Riley Bove, MD, FAAN |
02:05 PM - 02:25 PM EDT | Speaker |
Neuroendocrine Effects on Headache
Michael A. Rogawski, MD, PhD |
02:25 PM - 02:45 PM EDT | Speaker |
Effects of Neurotrauma on the Neuroendocrine System
Gary M. Abrams, MD, FAAN |
02:45 PM - 03:00 PM EDT | Q&A |
Questions and Answers
|
Alison M. Pack, MD, FAAN | An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care. |
Karen K. Miller, MD | Dr. Klahr Miller has stock in Amgen. Dr. Klahr Miller has stock in Bristol-Myers Squibb . Dr. Klahr Miller has stock in GE. Dr. Klahr Miller has stock in Boston Scientific. Dr. Klahr Miller has stock in Becton Dickinson. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . An immediate family member of Dr. Klahr Miller has stock in GE. An immediate family member of Dr. Klahr Miller has stock in Boston Scientific. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . The institution of Dr. Klahr Miller has received research support from Amgen. The institution of Dr. Klahr Miller has received research support from Pfizer. Dr. Klahr Miller has received publishing royalties from a publication relating to health care. |
Riley Bove, MD, FAAN | Dr. Bove has nothing to disclose. |
Gary M. Abrams, MD, FAAN | No disclosure on file |
Michael A. Rogawski, MD, PhD | Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals. |